IRVINE, December 19, 2019 – The High Desert Heart Institute in California, part of nationwide Prime Healthcare group, has signed a partnership with Coala Life to utilize the Coala Heart Monitor on a broad scale. The agreement constitutes the first major healthcare provider contract for Coala Life in the US following recent market launch. Clinical …
STOCKHOLM, DECEMBER 11, 2019 – In order to continue our strategic drive to grow the health care business and align our sales and marketing efforts the role Chief Commercial Officer has been created. With the recent FDA clearance for Coala in the US and the subsequent launch in the US, Germany and soon the Netherlands, …
STOCKHOLM, November 22, 2019 – Implementation of the Coala Heart Monitor leads to higher clinical efficiency, lower costs, shorter waiting lists and higher patient satisfaction. That is the results of a clinical evaluation performed at the Cardiology Clinic at Aleris Sabbatsberg. In 2019, Aleris Cardiology Clinic at Sabbatsberg hospital used Coala Heart Monitor to …
Irvine, CA, US – October 2nd, 2019 – Swedish digital health company Coala Life today announced its market launch in the US in collaboration with leading US cardiologists and healthcare providers. The launch follows recent FDA clearance for the Coala Heart Monitor and subsequent A-series funding. The Coala Heart Monitor (“Coala”) is a real-time …
STOCKHOLM August 30, 2019 – Today Coala Life announces entry into the Dutch market in partnership with Luscii. The Netherlands, with healthcare expenditures approaching $100 Bn, is a major and influential hub in the European medical device industry frequently ranked in the top 5 global medical device markets. The Swedish medtech company Coala Life, …
STOCKHOLM, JUNE 27th, 2019. Coala Life today announced the expanded closing of previously announced A-series round of approximately SEK 11 million. The proceeds are intended to accelerate the commercialization process and establish the company on the US market. Investors includes the investment company Blue and members of the management team. Swedish medical technology company Coala …
STOCKHOLM 2019-06-20. The Board of Directors at Coala Life has appointed Dan Pitulia as the new CEO of Coala Life AB effective July 1st, 2019. Philip Siberg, the current CEO and co-founder, will lead Coalas entry on the US market as the new head of Coala Life Inc. Additional key individuals have been recruited as …
STOCKHOLM June 12, 2019 – Today Coala Life announces international expansion and entry into the German market. Coala Life has partnered with Arteriomed GmbH, a leader in supplying the German market with patient-centered medical solutions. Germany is the largest medical device market in the European Union and Coala Life’s products will be available on the …
STOCKHOLM April 24, 2019 – Coala Life today announces the closing of an A-series round of approximately USD 10 million (SEK 92 million) raised from Swedish institutional and private investors. The proceeds are intended to accelerate the commercialization and establish the company on the US market. Investors include 20 North Street, Larry Leksell, Anders Nyrén …
